Overview

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults.
Details
Lead Sponsor:
Novo Nordisk A/S